Literature DB >> 21442148

The paradigm of G protein receptor transactivation: a mechanistic definition and novel example.

Peter J Little1, Micah L Burch, Sefaa Al-aryahi, Wenhua Zheng.   

Abstract

Seven transmembrane G protein-coupled receptors are among the most common in biology and they transduce cellular signals from a plethora of hormones. As well as their own well-characterized signaling pathways, they can also transactivate tyrosine kinase growth factor receptors to greatly expand their own cellular repertoire of responses. Recent data in vascular smooth muscle cells have expanded the breadth of transactivation to include serine/threonine kinase receptors, specifically the receptor for transforming growth factor beta (TGF-beta). Stimulation with endothelin and thrombin leads to the rapid formation of C-terminal phosphorylated Smad2, which is the immediate product of activation of the TGF-beta receptor. Additionally, it appears that no definition of transactivation based on mechanism is available, so we have provided a definition involving temporal aspects and the absence of de novo protein synthesis. The phenomenon of transactivation is an important biochemical mechanism and potential drug target in multiple diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21442148      PMCID: PMC5720110          DOI: 10.1100/tsw.2011.75

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  12 in total

Review 1.  G Protein Coupled Receptor-mediated Transactivation of Extracellular Proteases.

Authors:  Allison E Schafer; Burns C Blaxall
Journal:  J Cardiovasc Pharmacol       Date:  2017-07       Impact factor: 3.105

Review 2.  The expansion of GPCR transactivation-dependent signalling to include serine/threonine kinase receptors represents a new cell signalling frontier.

Authors:  Danielle Kamato; Muhamad Ashraf Rostam; Rebekah Bernard; Terrence J Piva; Nitin Mantri; Daniel Guidone; Wenhua Zheng; Narin Osman; Peter J Little
Journal:  Cell Mol Life Sci       Date:  2014-11-12       Impact factor: 9.261

3.  Proteinase-activated receptor 1- and 4-promoted migration of Hep3B hepatocellular carcinoma cells depends on ROS formation and RTK transactivation.

Authors:  Franziska Mußbach; Petra Henklein; Martin Westermann; Utz Settmacher; Frank-D Böhmer; Roland Kaufmann
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-06       Impact factor: 4.553

4.  Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells.

Authors:  Francesca Spinella; Valentina Caprara; Valeriana Di Castro; Laura Rosanò; Roberta Cianfrocca; Pier Giorgio Natali; Anna Bagnato
Journal:  J Mol Med (Berl)       Date:  2012-09-11       Impact factor: 4.599

5.  Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts.

Authors:  Paola Cipriani; Paola Di Benedetto; Piero Ruscitti; Daniela Verzella; Mariafausta Fischietti; Francesca Zazzeroni; Vasiliki Liakouli; Francesco Carubbi; Onorina Berardicurti; Edoardo Alesse; Roberto Giacomelli
Journal:  Arthritis Res Ther       Date:  2015-09-10       Impact factor: 5.156

Review 6.  Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact.

Authors:  Frank Gieseler; Hendrik Ungefroren; Utz Settmacher; Morley D Hollenberg; Roland Kaufmann
Journal:  Cell Commun Signal       Date:  2013-11-11       Impact factor: 5.712

Review 7.  Cell-surface receptors transactivation mediated by g protein-coupled receptors.

Authors:  Fabio Cattaneo; Germano Guerra; Melania Parisi; Marta De Marinis; Domenico Tafuri; Mariapia Cinelli; Rosario Ammendola
Journal:  Int J Mol Sci       Date:  2014-10-29       Impact factor: 5.923

8.  Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5.

Authors:  Franziska Zeeh; David Witte; Thomas Gädeken; Bernhard H Rauch; Evelin Grage-Griebenow; Nadja Leinung; Sofie Joline Fromm; Stephanie Stölting; Koichiro Mihara; Roland Kaufmann; Utz Settmacher; Hendrik Lehnert; Morley D Hollenberg; Hendrik Ungefroren
Journal:  Oncotarget       Date:  2016-07-05

Review 9.  Signaling Crosstalk of TGF-β/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer.

Authors:  Hendrik Ungefroren; Frank Gieseler; Roland Kaufmann; Utz Settmacher; Hendrik Lehnert; Bernhard H Rauch
Journal:  Int J Mol Sci       Date:  2018-05-24       Impact factor: 5.923

Review 10.  Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11.

Authors:  Danielle Kamato; Lyna Thach; Rebekah Bernard; Vincent Chan; Wenhua Zheng; Harveen Kaur; Margaret Brimble; Narin Osman; Peter J Little
Journal:  Front Cardiovasc Med       Date:  2015-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.